[Critical evaluation of the protracted use of somatostatin in the conservative treatment of complex pancreatico-duodenal fistulas].
The authors refer to their experience in dealing with prolonged intravenous infusion of Somatostatin in treating two cases of complicated duodenal-pancreatic fistula. The results confirm the therapeutic efficiency in accelerating the healing process without any side effects of the drug.
D002763:Cholecystectomy; D004322:Drainage / Q000295:instrumentation; D004341:Drug Evaluation; D004378:Duodenal Diseases / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery; D042882:Gallstones / Q000601:surgery; D006801:Humans; D007412:Intestinal Fistula / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery; D007773:Lactates / Q000008:administration & dosage; D019344:Lactic Acid; D008297:Male; D010185:Pancreatic Fistula / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery; D010289:Parenteral Nutrition, Total; D011183:Postoperative Complications; D013004:Somatostatin / Q000008:administration & dosage*; D013396:Suction / Q000295:instrumentation; D013997:Time Factors
D007773:Lactates; D019344:Lactic Acid; D013004:Somatostatin
Valutazione critica dell'impiego protratto della somatostatina nella terapia conservativa delle fistole complesse pancreatico-duodenali.